Statistics
Publications
1
Citations
26
H-Index
1
Active since
2024
Affiliations
Sanofi (United States)(Current)
Lei Wang is an author at Sanofi (United States) specializing in myeloid-derived suppressor cell function, immunotherapy, and tumor microenvironment effects.
Publications per year
2024–2024
1
1
PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy
Lei Wang, Yufeng Xiao, Yuewan Luo et al. · The Journal of Experimental Medicine · 2024 · 26 citations · Full text
Medicine, Immunology, Oncology +17
1–1 of 1